AB Science, акция обыкновенная (FR0010557264, AB, 0Q77, A8D)

AB Science is a pharmaceutical company specializing in the research, development, and commercialization of tyrosine kinase inhibitors, a new class of targeted therapeutic molecules which act by modifying signalling pathways within cells. The company focuses its research on pathologies with high unmet medical need (cancers, inflammatory diseases and central nervous system diseases) in human and veterinary medicine.

• AB Science, Варрант, FR001400ZRT0
• AB Science, Варрант, FR00140118Z8
• AB Science, Варрант, FR0014011S49

• Выручка
• Чистая прибыль
• EBITDA
• Активы
• Капитал
• Рентабельность по EBITDA (%)
• Чистый долг / EBITDA
• Общий долг / Капитал